R. Nakanishi et al., IMPROVED AIRWAY HEALING USING BASIC FIBROBLAST GROWTH-FACTOR IN A CANINE TRACHEAL - AUTOTRANSPLANTATION MODEL, Annals of surgery, 227(3), 1998, pp. 446-454
Objective We studied 22 dogs to examine the effect of basic fibroblast
growth factor (bFGF) alone, in comparison with omental or muscular wr
apping on airway healing in a tracheal autotransplantation model. Summ
ary Background Data Basic fibroblast growth factor is one of the most
potent promoters of angiogenesis and has an ability to enhance blood s
upply to the ischemic airway. Topical administration of a fibrin glue
enriched with 5 mu g/cm(2) bFGF, determined as a proportion of surface
area of the tracheal grafts, improved revascularization of orthotopic
canine tracheal autografts in a previous study, Methods All animals r
eceived orthotopic tracheal transplantation using 6-ring autografts th
at occupied a distal part of the thoracic trachea. Twenty-two animals
were classified randomly into the following four groups: no treatment
(Group G1, n = 4), muscular wrapping (Group G2, n = 4), omental wrappi
ng (Group G3, n = 4), and topical administration of fibrin glue enrich
ed with 5 mu g/cm(2) bFGF (Group G4, n = 10), Autografts were harveste
d 60 days after transplantation and assessed by the percent patency an
d histology. Results Devascularized tracheal autografts could not main
tain their structural integrity without other treatments (Group G1). I
n contrast, more than half of ail autografts receiving treatments rema
ined viable, as demonstrated by gross and histologic findings (Groups
G2, G3, and G4). Treatments with bFGF and omentum showed significantly
better graft viability than no treatment. However, there was no stati
stical difference in the viability of tracheal autografts among the th
ree treatment groups. In terms of the time performance ratio, bFGF was
the best treatment for the devascularized autografts, Conclusions Top
ical administration of bFGF was superior to the omental or muscular wr
apping in terms of the time performance ratio. Clinical trials will be
necessary to determine whether these findings are applicable to human
s.